H. Lundbeck A/S (CPH:HLUN.B)
Denmark · Delayed Price · Currency is DKK 40.56
+1.48 (3.79%)
Aug 27, 2025, 4:59 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Rexulti | 5.20B | Log In | Log In | Log In | Log In | Upgrade |
Rexulti Growth | 14.96% | Log In | Log In | Log In | Log In | Upgrade |
Brintellix/Trintellix | 4.85B | Log In | Log In | Log In | Log In | Upgrade |
Brintellix/Trintellix Growth | 12.10% | Log In | Log In | Log In | Log In | Upgrade |
Abilify Long-acting Injectable Franchise | 3.50B | Log In | Log In | Log In | Log In | Upgrade |
Abilify Long-acting Injectable Franchise Growth | 9.95% | Log In | Log In | Log In | Log In | Upgrade |
Other Pharmaceuticals | 3.18B | Log In | Log In | Log In | Log In | Upgrade |
Other Pharmaceuticals Growth | -1.97% | Log In | Log In | Log In | Log In | Upgrade |
Vyepti | 2.91B | Log In | Log In | Log In | Log In | Upgrade |
Vyepti Growth | 71.42% | Log In | Log In | Log In | Log In | Upgrade |
Cipralex/Lexapro | 2.05B | Log In | Log In | Log In | Log In | Upgrade |
Cipralex/Lexapro Growth | -4.07% | Log In | Log In | Log In | Log In | Upgrade |
Reconciling Items | 366.00M | Log In | Log In | Log In | Log In | Upgrade |
Reconciling Items Growth | 11.93% | Log In | Log In | Log In | Log In | Upgrade |
Exceptional Items | -52.00M | Log In | Log In | Log In | Log In | Upgrade |
Exceptional Items Growth | -137.96% | Log In | Log In | Log In | Log In | Upgrade |
Sabril | - | Log In | Log In | Log In | Log In | Upgrade |
Sabril Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Onfi | - | Log In | Log In | Log In | Log In | Upgrade |
Onfi Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Northera | - | Log In | Log In | Log In | Log In | Upgrade |
Northera Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Reconciling Items | 366.00M | Log In | Log In | Log In | Log In | Upgrade |
Reconciling Items Growth | 11.93% | Log In | Log In | Log In | Log In | Upgrade |
Exceptional Items | -52.00M | Log In | Log In | Log In | Log In | Upgrade |
Exceptional Items Growth | -137.96% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Reconciling Items | 366.00M | Log In | Log In | Log In | Log In | Upgrade |
Reconciling Items Growth | 11.93% | Log In | Log In | Log In | Log In | Upgrade |
Exceptional Items | -52.00M | Log In | Log In | Log In | Log In | Upgrade |
Exceptional Items Growth | -137.96% | Log In | Log In | Log In | Log In | Upgrade |
United States | 11.33B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 15.22% | Log In | Log In | Log In | Log In | Upgrade |
International | 5.22B | Log In | Log In | Log In | Log In | Upgrade |
International Growth | 4.57% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 5.13B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 11.21% | Log In | Log In | Log In | Log In | Upgrade |
Reconciling Items | 366.00M | Log In | Log In | Log In | Log In | Upgrade |
Reconciling Items Growth | 11.93% | Log In | Log In | Log In | Log In | Upgrade |
Denmark | 15.00M | Log In | Log In | Log In | Log In | Upgrade |
Denmark Growth | 7.14% | Log In | Log In | Log In | Log In | Upgrade |
Exceptional Items | -52.00M | Log In | Log In | Log In | Log In | Upgrade |
Exceptional Items Growth | -137.96% | Log In | Log In | Log In | Log In | Upgrade |
North America | - | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | - | Log In | Log In | Log In | Log In | Upgrade |